Filtered By:
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 7385 results found since Jan 2013.
ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone
J Med Toxicol. 2023 Aug 7. doi: 10.1007/s13181-023-00960-4. Online ahead of print.NO ABSTRACTPMID:37548894 | DOI:10.1007/s13181-023-00960-4
Source: Journal of Medical Toxicology - August 7, 2023 Category: Toxicology Authors: Maryann Mazer-Amirshahi Andrew I Stolbach Peggy Ye Source Type: research
Use of ICS and Fast-Acting Bronchodilators in Asthma: Past, Present, and Future
J Fam Pract. 2023 Jul;72(6 Suppl):S61-S70. doi: 10.12788/jfp.0625.ABSTRACTPrimary care practitioners (PCPs) play a key role in asthma management since most patients with asthma are treated in primary care settings. Despite continual advances in asthma care, important practice gaps remain, and the high burden of asthma exacerbations persists, with 43% of children with asthma and 41% of adults with asthma in the United States experiencing an asthma exacerbation in 2020. Uncontrolled asthma, incomplete assessment of exacerbation and asthma control history, reliance on systemic corticosteroids (SCS) or short-acting beta2-agoni...
Source: The Journal of Family Practice - August 7, 2023 Category: Practice Management Authors: Neil Skolnik Marissa Norden Njira Lugogo Wendy Wright Source Type: research
Insomnia Management: A Review and Update
J Fam Pract. 2023 Jul;72(6 Suppl):S31-S36. doi: 10.12788/jfp.0620.ABSTRACTInsomnia is a distinct disorder that is common, yet underrecognized and undertreated in primary care. Treating insomnia has been shown to improve outcomes, including reduced risk of developing cardiovascular and mental health disorders. Insomnia is influenced by the brain's regulation of sleep and wake, which are mutually exclusive events. Insomnia should be treated as a distinct condition, even when occurring with a comorbid diagnosis such as depression or anxiety. Clinicians should implement a multimodal approach to insomnia management, including n...
Source: The Journal of Family Practice - August 7, 2023 Category: Practice Management Authors: David P Shaha Source Type: research
Use of ICS and Fast-Acting Bronchodilators in Asthma: Past, Present, and Future
J Fam Pract. 2023 Jul;72(6 Suppl):S61-S70. doi: 10.12788/jfp.0625.ABSTRACTPrimary care practitioners (PCPs) play a key role in asthma management since most patients with asthma are treated in primary care settings. Despite continual advances in asthma care, important practice gaps remain, and the high burden of asthma exacerbations persists, with 43% of children with asthma and 41% of adults with asthma in the United States experiencing an asthma exacerbation in 2020. Uncontrolled asthma, incomplete assessment of exacerbation and asthma control history, reliance on systemic corticosteroids (SCS) or short-acting beta2-agoni...
Source: The Journal of Family Practice - August 7, 2023 Category: Practice Management Authors: Neil Skolnik Marissa Norden Njira Lugogo Wendy Wright Source Type: research
Insomnia Management: A Review and Update
J Fam Pract. 2023 Jul;72(6 Suppl):S31-S36. doi: 10.12788/jfp.0620.ABSTRACTInsomnia is a distinct disorder that is common, yet underrecognized and undertreated in primary care. Treating insomnia has been shown to improve outcomes, including reduced risk of developing cardiovascular and mental health disorders. Insomnia is influenced by the brain's regulation of sleep and wake, which are mutually exclusive events. Insomnia should be treated as a distinct condition, even when occurring with a comorbid diagnosis such as depression or anxiety. Clinicians should implement a multimodal approach to insomnia management, including n...
Source: The Journal of Family Practice - August 7, 2023 Category: Practice Management Authors: David P Shaha Source Type: research
Use of ICS and Fast-Acting Bronchodilators in Asthma: Past, Present, and Future
J Fam Pract. 2023 Jul;72(6 Suppl):S61-S70. doi: 10.12788/jfp.0625.ABSTRACTPrimary care practitioners (PCPs) play a key role in asthma management since most patients with asthma are treated in primary care settings. Despite continual advances in asthma care, important practice gaps remain, and the high burden of asthma exacerbations persists, with 43% of children with asthma and 41% of adults with asthma in the United States experiencing an asthma exacerbation in 2020. Uncontrolled asthma, incomplete assessment of exacerbation and asthma control history, reliance on systemic corticosteroids (SCS) or short-acting beta2-agoni...
Source: The Journal of Family Practice - August 7, 2023 Category: Practice Management Authors: Neil Skolnik Marissa Norden Njira Lugogo Wendy Wright Source Type: research
Insomnia Management: A Review and Update
J Fam Pract. 2023 Jul;72(6 Suppl):S31-S36. doi: 10.12788/jfp.0620.ABSTRACTInsomnia is a distinct disorder that is common, yet underrecognized and undertreated in primary care. Treating insomnia has been shown to improve outcomes, including reduced risk of developing cardiovascular and mental health disorders. Insomnia is influenced by the brain's regulation of sleep and wake, which are mutually exclusive events. Insomnia should be treated as a distinct condition, even when occurring with a comorbid diagnosis such as depression or anxiety. Clinicians should implement a multimodal approach to insomnia management, including n...
Source: The Journal of Family Practice - August 7, 2023 Category: Practice Management Authors: David P Shaha Source Type: research
ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone
J Med Toxicol. 2023 Aug 7. doi: 10.1007/s13181-023-00960-4. Online ahead of print.NO ABSTRACTPMID:37548894 | DOI:10.1007/s13181-023-00960-4
Source: Journal of Medical Toxicology - August 7, 2023 Category: Toxicology Authors: Maryann Mazer-Amirshahi Andrew I Stolbach Peggy Ye Source Type: research
Use of ICS and Fast-Acting Bronchodilators in Asthma: Past, Present, and Future
J Fam Pract. 2023 Jul;72(6 Suppl):S61-S70. doi: 10.12788/jfp.0625.ABSTRACTPrimary care practitioners (PCPs) play a key role in asthma management since most patients with asthma are treated in primary care settings. Despite continual advances in asthma care, important practice gaps remain, and the high burden of asthma exacerbations persists, with 43% of children with asthma and 41% of adults with asthma in the United States experiencing an asthma exacerbation in 2020. Uncontrolled asthma, incomplete assessment of exacerbation and asthma control history, reliance on systemic corticosteroids (SCS) or short-acting beta2-agoni...
Source: The Journal of Family Practice - August 7, 2023 Category: Practice Management Authors: Neil Skolnik Marissa Norden Njira Lugogo Wendy Wright Source Type: research
Insomnia Management: A Review and Update
J Fam Pract. 2023 Jul;72(6 Suppl):S31-S36. doi: 10.12788/jfp.0620.ABSTRACTInsomnia is a distinct disorder that is common, yet underrecognized and undertreated in primary care. Treating insomnia has been shown to improve outcomes, including reduced risk of developing cardiovascular and mental health disorders. Insomnia is influenced by the brain's regulation of sleep and wake, which are mutually exclusive events. Insomnia should be treated as a distinct condition, even when occurring with a comorbid diagnosis such as depression or anxiety. Clinicians should implement a multimodal approach to insomnia management, including n...
Source: The Journal of Family Practice - August 7, 2023 Category: Practice Management Authors: David P Shaha Source Type: research
